Michael Larbig, MD PhD, is a dedicated physician with over 15 years of experience in drug development across academia and the pharmaceutical industry. Currently serving as the Executive Director and Global Clinical Program Leader at CSL since 2022, Michael has expertise in clinical trial design methodology from phase I to IV, focusing on respiratory medicine and immunology. They previously held key positions at CSL Behring, Novartis, and Fraunhofer ITEM, contributing to significant clinical studies and innovative research methodologies. Michael completed specialist training in Pediatrics at Hanover Medical School and has a research fellowship in molecular pathology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices